2011
DOI: 10.1016/j.ijantimicag.2011.01.026
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

5
51
1
2

Year Published

2013
2013
2018
2018

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 54 publications
(59 citation statements)
references
References 32 publications
5
51
1
2
Order By: Relevance
“…Our results showed that the PK/PD targets (C max /MIC ratio Ն 8, AUC/MIC Ն 70) were achieved with a dosing regimen of 25 mg/kg or higher in critically ill patients undergoing CVVH or CVVHDF. These results are consistent with those reported by Taccone et al (11). They reported that a 25-mg/kg loading dose of amikacin in patients undergoing CVVHDF at a dose of 30 ml/kg/h and a blood flow rate setting at 150 to 200 ml/min achieved the targeted C max of 64 mg/liter in 9 (69%) pa- tients.…”
Section: Discussionsupporting
confidence: 92%
See 4 more Smart Citations
“…Our results showed that the PK/PD targets (C max /MIC ratio Ն 8, AUC/MIC Ն 70) were achieved with a dosing regimen of 25 mg/kg or higher in critically ill patients undergoing CVVH or CVVHDF. These results are consistent with those reported by Taccone et al (11). They reported that a 25-mg/kg loading dose of amikacin in patients undergoing CVVHDF at a dose of 30 ml/kg/h and a blood flow rate setting at 150 to 200 ml/min achieved the targeted C max of 64 mg/liter in 9 (69%) pa- tients.…”
Section: Discussionsupporting
confidence: 92%
“…In a previous study, we highlighted that the use of a regimen with a higher dose (30 mg/kg) in association with therapeutic drug monitoring led to extended dosing intervals in half of the critically ill patients studied (28). Taccone et al reported that the median time to achieve a trough concentration below 5 mg/liter was 36 h (IQR, 14 to 76 h) in patients undergoing CVVHDF (11). The extended dosing in- tervals suggested by the results of the present study are consistent with recommendations for aminoglycoside dosing regimens in critically ill patients receiving continuous RRT (30)(31)(32).…”
Section: Discussionsupporting
confidence: 87%
See 3 more Smart Citations